Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet (Q43268256)

17 November 2017

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet (English)

1 reference

17 November 2017

0 references

1 reference

1 reference

1 reference

4

Teruo Kawada

1 reference

17 November 2017

Ji-Hye Kang

1

1 reference

17 November 2017

Tsuyoshi Goto

2

1 reference

17 November 2017

In-Seob Han

3

1 reference

17 November 2017

Young Min Kim

5

1 reference

17 November 2017

Rina Yu

6

1 reference

17 November 2017

1 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

18

1 reference

17 November 2017

780-787

1 reference

17 November 2017

4

1 reference

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

17 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Obesity is associated with macrophage accumulation in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Adiponectin and Metabolic Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

The biology of white adipocyte proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Inflammation and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

TNF-alpha and adipocyte biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Monocyte chemoattractant protein 1 in obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Capsicum--production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

PPARs, Obesity, and Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Tyrosine-dependent and -independent actions of leptin receptor in control of energy balance and glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.301

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.301

1 reference

17 November 2017

1 reference